All articles by Umesh Ellichipuram

Umesh Ellichipuram

PRA Health Sciences introduces Patient-Centric Trial Development Toolkit

US-based contract research company PRA Health Sciences has launched its Patient-Centric Trial Development Toolkit to identify and mitigate risks to rare disease clinical programmes.

Instem acquires clinical trial technology provider d-wise

Instem has acquired clinical trial technology and consulting company d-wise to further accelerate life science development.

PathAI and Labcorp partner for algorithms in oncology trials

PathAI and Labcorp have expanded their strategic collaboration, which will enable the deployment of the former’s algorithms in prospective clinical trials of cancer and other diseases.

LSK Global selects Veeva’s clinical applications to simplify trial processes

Korean contract research organisation LSK Global Pharma Services has adopted three Veeva vault clinical applications to streamline the global trial processes.

Science 37 signs partnership agreement with Medgate for clinical trials

Science 37 has collaborated with digital health and telemedicine company Medgate to further globalise decentralised clinical trials.

Saama Technologies and Oracle partner to expedite clinical trials

Saama Technologies has partnered with Oracle to offer life sciences industry artificial intelligence (AI) enabled applications to accelerate clinical trials.

Medable to integrate Seqster technology in decentralised trial platform

Medable has collaborated with healthcare technology company Seqster to integrate real-world patient data streams in decentralised clinical trials platform.

Leidos to conduct clinical trials for Covid-19 therapeutics

The Defense Threat Reduction Agency (DTRA) in the US has awarded a new project agreement to Leidos to conduct clinical trials for Covid-19 therapeutics.

Solano Hematology selects VIPER for clinical trial recruitment

Solano Hematology Oncology has adopted Deep Lens’ artificial intelligence-based platform VIPER to improve patient access to clinical oncology trials.

Ireland’s ICON signs agreement to acquire PRA Health Sciences

Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a cash and stock deal valued at about $12bn.